학술논문
Nomenclature of HBV core protein-targeting antivirals
Document Type
Brief Communication
Author
Source
Nature Reviews Gastroenterology & Hepatology. 19(12):748-750
Subject
Language
English
ISSN
1759-5045
1759-5053
1759-5053
Abstract
Hepatitis B virus (HBV) core protein-targeting compounds are in or entering clinical development without a standardized nomenclature. We propose a naming convention for these core-targeting antiviral products to provide clarity and accelerate HBV drug development.